Find clinical trials for Triple Negative Breast Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Phoenix, AZ, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple...
Phase 1
Gilbert, Arizona, United States and 8 other locations
or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...
Phase 2
Phoenix, Arizona, United States and 44 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
Goodyear, Arizona, United States and 46 other locations
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...
Phase 3
Gilbert, Arizona, United States and 70 other locations
in patients with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received a...
Phase 2
Chandler, Arizona, United States and 21 other locations
selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...
Phase 2
Chandler, Arizona, United States and 23 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Glendale, Arizona, United States and 131 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC) or non-sma...
Phase 1
Scottsdale, Arizona, United States and 17 other locations
the RP2D. The RP2D will be administered to 3 cohorts of patients in the Dose Expansion Phase.Cohort A: Advanced or Metastatic Triple Negative...
Phase 1, Phase 2
Phoenix, Arizona, United States and 15 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Tempe, Arizona, United States and 357 other locations
Clinical trials
Research sites
Resources
Legal